EUVIMEDEUVIMED entdecken
Open Access

Broad-spectrum synthetic carbohydrate receptors (SCRs) inhibit viral entry across multiple virus families

Shahrzad Ezzatpour iD, Khushabu Thakur iD, Kenneth Erzoah Ndede iD, David W Buchholz iD, Annette Choi iD, Brian Imbiakha iD, Jordan Carter iD, David Onofrei iD, Brett Eaton iD, Elena Postnikova iD, Michael Murphy, Beicer C Tapia iD und 21 weitere

Science Advances · 29.08.2025 · 11 (35)

DOI: 10.1126/sciadv.ady3554 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Science Advances, erschienen am 29.08.2025. Verfasst von Shahrzad Ezzatpour und 32 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology and Immunology, Cornell University College of Veterinary Medicine, Ithaca, NY 14853, USA. Hauptthemen laut MEDLINE: Virus Internalization, Antiviral Agents, Receptors, Virus. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 97 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAID NIH HHS, NIGMS NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Viral pandemics continue to threaten global health and economic stability. Despite medical advances, the absence of broad-spectrum antivirals (BSAs) prevents rapid responses to emerging viral threats. This is largely due to the lack of universal drug targets across diverse viral families and high variability among viral proteins. In this study, we evaluated 57 synthetic carbohydrate receptors (SCRs) for antiviral activity in cellulo using pseudotyped virus particles (PVPs) from six high-risk viruses across three families: Paramyxoviridae, Filoviridae, and Coronaviridae. Four SCRs inhibited all tested PVPs, and their efficacy was confirmed against live viruses including SARS-CoV-2, MERS-CoV, EBOV, MARV, NiV, and HeV. Notably, SCR005 and SCR007 , which exhibited minimal toxicity, significantly reduced SARS-CoV-2 infection in a severe animal model with a single dose. Mechanistic studies suggested that SCRs bind viral envelope N-glycans, blocking viral attachment and/or fusion. These results identify conserved viral N-glycans as promising BSA targets and establish SCRs as candidate prophylactic agents against enveloped viruses with pandemic potential.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Virus InternalizationAntiviral AgentsReceptors, VirusAnimalsHumansSARS-CoV-2COVID-19Vero Cells

Substanzen

Antiviral AgentsReceptors, Virus

Autor:innen und Institutionen

  • Department of Microbiology and Immunology, Cornell University College of Veterinary Medicine, Ithaca, NY 14853, USA.
  • Department of Microbiology, College of Agriculture and Life Sciences, Cornell University, Ithaca, NY.
  • Advanced Science Research Center at The Graduate Center of the City University of New York 85 St Nicholas Terrace, New York, NY 10031 USA.
  • Department of Chemistry and Biochemistry, Hunter College, 695 Park Ave., New York, NY 10065 USA.
  • Graduate program in Chemistry, Graduate Center of the City University of New York, 365 5th Ave., New York, NY 10016 (USA).
  • Department of Chemistry and Biochemistry, San Diego State University, San Diego, CA 92182 USA.

ORCID-Profile: Shahrzad Ezzatpour, Khushabu Thakur, Kenneth Erzoah Ndede, David W Buchholz, Annette Choi, Brian Imbiakha, Jordan Carter, David Onofrei, Brett Eaton, Elena Postnikova, Beicer C Tapia, Siddharth Pasari, Anthony Russo, Gregory P Holland, Michael R Holbrook, Sara L Caddy, Seyed Mohammad Davachi, Isaac Abrrey Monreal, Julie Sahler, Victoria Ortega, Jose M Miranda, Gary R Whittaker, Mason C Jager, Pradeep Chopra, Geert Jan-Boons, Mateusz Marianski, Adam B Braunschweig, Hector C Aguilar

Förderung

  • NIAID NIH HHS
  • NIGMS NIH HHS

Zitieren

APA

Ezzatpour, S., Thakur, K., Erzoah Ndede, K., Buchholz, D. W., Choi, A., Imbiakha, B., Carter, J., Onofrei, D., Eaton, B., Postnikova, E., Murphy, M., Tapia, B. C., Bello, D., Pasari, S., Russo, A., Babayev, M., Holland, G. P., Holbrook, M. R., Caddy, S. L., …, & Aguilar, H. C. (2025). Broad-spectrum synthetic carbohydrate receptors (SCRs) inhibit viral entry across multiple virus families. Science Advances, 11(35). https://doi.org/10.1126/sciadv.ady3554

Vancouver

Ezzatpour S, Thakur K, Erzoah Ndede K, Buchholz DW, Choi A, Imbiakha B, et al. Broad-spectrum synthetic carbohydrate receptors (SCRs) inhibit viral entry across multiple virus families. Science Advances. 2025;11(35). doi:10.1126/sciadv.ady3554

BibTeX
@article{Ezzatpour2025,
  author = {Ezzatpour, Shahrzad and Thakur, Khushabu and Erzoah Ndede, Kenneth and Buchholz, David W and Choi, Annette and Imbiakha, Brian and Carter, Jordan and Onofrei, David and Eaton, Brett and Postnikova, Elena and Murphy, Michael and Tapia, Beicer C and Bello, Diana and Pasari, Siddharth and Russo, Anthony and Babayev, Matthew and Holland, Gregory P and Holbrook, Michael R and Caddy, Sara L and Moran, Steven J and Davachi, Seyed Mohammad and Monreal, Isaac Abrrey and Sahler, Julie and Ortega, Victoria and Miranda, Jose M and Whittaker, Gary R and Jager, Mason C and Bhagwat, Seema K and Chopra, Pradeep and Jan-Boons, Geert and Marianski, Mateusz and Braunschweig, Adam B and Aguilar, Hector C},
  title = {Broad-spectrum synthetic carbohydrate receptors (SCRs) inhibit viral entry across multiple virus families},
  journal = {Science Advances},
  year = {2025},
  volume = {11},
  number = {35},
  doi = {10.1126/sciadv.ady3554}
}
Kostenlos starten →